Artal Group’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
2021
Q4
$4.96M Hold
2021
Q3
$8.31M Hold
2021
Q2
$7.27M Hold
2021
Q1
$8.28M Hold
2020
Q4
$8.22M Hold
2020
Q3
$7.41M Sell
2020
Q2
$10.2M Buy
2020
Q1
$1.86M Buy
2019
Q4
$2.29M Hold
2019
Q3
$2.31M Buy
2019
Q2
$1.16M Buy